Work

Abstract LB014: HSK46256, a highly selective and brain penetrable PARP1 inhibitor for the treatment of HRD cancers

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb014

Authors: Fan Li, Haisco Pharmaceutical Group, Lei Chen, Yao Li, Qingyuan Meng, Ju Wang, Pangke Yan, Pingming Tang

Institution: Haisco Pharmaceutical Group Co., Ltd. (China)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821603

Cites:

Cited by: 1

Related to: 10